Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
18,515
archived clinical trials in
Lymphoma

Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
A Phase II Multicenter Randomized Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
Status: Enrolling
Updated:  12/31/1969
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
A Phase II Multicenter Randomized Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
Status: Enrolling
Updated: 12/31/1969
Vanderbilt-Ingram Cancer Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
A Phase II Multicenter Randomized Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
Status: Enrolling
Updated:  12/31/1969
Simmons Cancer Center - Dallas
mi
from
Dallas, TX
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
A Phase II Multicenter Randomized Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
Status: Enrolling
Updated: 12/31/1969
Simmons Cancer Center - Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
A Phase II Multicenter Randomized Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
Status: Enrolling
Updated:  12/31/1969
Texas Transplant Institute
mi
from
San Antonio, TX
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
A Phase II Multicenter Randomized Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
Status: Enrolling
Updated: 12/31/1969
Texas Transplant Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
A Phase II Multicenter Randomized Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
Status: Enrolling
Updated:  12/31/1969
Massey Cancer Center
mi
from
Richmond, VA
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
A Phase II Multicenter Randomized Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
Status: Enrolling
Updated: 12/31/1969
Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
A Phase II Multicenter Randomized Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
Status: Enrolling
Updated:  12/31/1969
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
A Phase II Multicenter Randomized Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
Status: Enrolling
Updated: 12/31/1969
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
A Phase II Multicenter Randomized Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
A Phase II Multicenter Randomized Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
A Phase II Multicenter Randomized Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
Status: Enrolling
Updated:  12/31/1969
Ottawa Regional Cancer Centre
mi
from
Ottawa,
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
A Phase II Multicenter Randomized Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
Status: Enrolling
Updated: 12/31/1969
Ottawa Regional Cancer Centre
mi
from
Ottawa,
Click here to add this to my saved trials
TRIAD Burden of Illness Mucositis Study
Risk and Outcomes of Mucositis in Subjects Being Treated for Breast, Colorectal, Head and Neck, Non-Small Cell Lung Cancers or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated:  4/19/2007
Univeristy Of Wisconsin
mi
from
Madison, WI
TRIAD Burden of Illness Mucositis Study
Risk and Outcomes of Mucositis in Subjects Being Treated for Breast, Colorectal, Head and Neck, Non-Small Cell Lung Cancers or Non-Hodgkin's Lymphoma
Status: Enrolling
Updated: 4/19/2007
Univeristy Of Wisconsin
mi
from
Madison, WI
Click here to add this to my saved trials
Immunization Against Tumor Cells in Sezary Syndrome
Phase II Evaluation of Immunization Against Tumor Cells in Subjects With Sezary Syndrome Using Autologous Mature Dendritic Cells
Status: Enrolling
Updated:  9/27/2007
University of Pittsburgh Medical Center, Department of Dermatology
mi
from
Pittsburgh, PA
Immunization Against Tumor Cells in Sezary Syndrome
Phase II Evaluation of Immunization Against Tumor Cells in Subjects With Sezary Syndrome Using Autologous Mature Dendritic Cells
Status: Enrolling
Updated: 9/27/2007
University of Pittsburgh Medical Center, Department of Dermatology
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Effect of Denileukin Diftitox on Immune System in CTCL Patients
Effect of Denileukin Diftitox in T-Regulatory Cells in CTCL Patients
Status: Enrolling
Updated:  12/26/2007
University of Pittsubrgh Medical Center
mi
from
Pittsburgh, PA
Effect of Denileukin Diftitox on Immune System in CTCL Patients
Effect of Denileukin Diftitox in T-Regulatory Cells in CTCL Patients
Status: Enrolling
Updated: 12/26/2007
University of Pittsubrgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma
A Phase I/II, Non-Randomized,Multiple-Dose,Dose Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of TNX-650 in Patients With Refractory Hodgkin's Lymphoma
Status: Enrolling
Updated:  5/8/2008
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma
A Phase I/II, Non-Randomized,Multiple-Dose,Dose Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of TNX-650 in Patients With Refractory Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/8/2008
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma
A Phase I/II, Non-Randomized,Multiple-Dose,Dose Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of TNX-650 in Patients With Refractory Hodgkin's Lymphoma
Status: Enrolling
Updated:  5/8/2008
MD Anderson Cancer Center - Dept. of Lymphoma and Myeloma
mi
from
Houston, TX
Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma
A Phase I/II, Non-Randomized,Multiple-Dose,Dose Escalation Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of TNX-650 in Patients With Refractory Hodgkin's Lymphoma
Status: Enrolling
Updated: 5/8/2008
MD Anderson Cancer Center - Dept. of Lymphoma and Myeloma
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma
A Phase I Multicenter, Open-Label, Dose-Escalating Clinical and Pharmacokinetic Study of PM00104 Administered Intravenously Over 1 Hour Daily for 5 Days, Every 3 Weeks, to Subjects With Advanced Malignant Solid Tumors or Lymphoma.
Status: Enrolling
Updated:  4/20/2009
Fox Chase Cancer Center
mi
from
Philadelphia, PA
A Phase I Study of Zalypsis (PM00104) in Subjects With Advanced Malignant Solid Tumors or Lymphoma
A Phase I Multicenter, Open-Label, Dose-Escalating Clinical and Pharmacokinetic Study of PM00104 Administered Intravenously Over 1 Hour Daily for 5 Days, Every 3 Weeks, to Subjects With Advanced Malignant Solid Tumors or Lymphoma.
Status: Enrolling
Updated: 4/20/2009
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma
A Pilot Phase II Study to Determine the Safety of the Combination of ONTAK (DAB389IL-2), an Interleukin-2 Fusion Toxin, in Combination With CHOP in Peripheral T-Cell Lymphoma
Status: Enrolling
Updated:  6/5/2009
Yale Comprehensive Cancer Center at Yale University School of Medicine
mi
from
New Haven, CT
A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma
A Pilot Phase II Study to Determine the Safety of the Combination of ONTAK (DAB389IL-2), an Interleukin-2 Fusion Toxin, in Combination With CHOP in Peripheral T-Cell Lymphoma
Status: Enrolling
Updated: 6/5/2009
Yale Comprehensive Cancer Center at Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma
Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermed.Grade B-Cell/T-Cell Lymphoma
Status: Enrolling
Updated:  6/5/2009
Yale Comprehensive Cancer Center at Yale University School of Medicine
mi
from
New Haven, CT
Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermediate-Grade B-Cell Lymphoma
Dose Escalation Study of Clofarabine in Patients With Relapsed or Refractory Low Grade or Intermed.Grade B-Cell/T-Cell Lymphoma
Status: Enrolling
Updated: 6/5/2009
Yale Comprehensive Cancer Center at Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas
A Phase I/II Trial of Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas
Status: Enrolling
Updated:  6/5/2009
Yale University School of Medicine
mi
from
New Haven, CT
Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas
A Phase I/II Trial of Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas
Status: Enrolling
Updated: 6/5/2009
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplantation
Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated:  5/3/2010
Massachusetts General Hospital
mi
from
Boston, MA
Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplantation
Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell Transplantation
Status: Enrolling
Updated: 5/3/2010
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
A Phase 1 Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma, for Which No Standard Therapy Is Available
Status: Enrolling
Updated:  5/13/2010
TGen Clinical Research Services at Scottsdale Healthcare
mi
from
Scottsdale, AZ
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
A Phase 1 Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma, for Which No Standard Therapy Is Available
Status: Enrolling
Updated: 5/13/2010
TGen Clinical Research Services at Scottsdale Healthcare
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
A Phase 1 Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma, for Which No Standard Therapy Is Available
Status: Enrolling
Updated:  5/13/2010
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma
A Phase 1 Study of AR-12 (2-Amino-N-[4-[5-(2 Phenanthrenyl)-3-(Trifluoromethyl)-1H-pyrazol-1-yl] Phenyl]-Acetamide) in Adult Patients With Advanced or Recurrent Solid Tumors or Lymphoma, for Which No Standard Therapy Is Available
Status: Enrolling
Updated: 5/13/2010
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma
Open-label Phase 2 Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma
Status: Enrolling
Updated:  5/27/2010
Florida Academic Dermatology Center
mi
from
Miami, FL
Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma
Open-label Phase 2 Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma
Status: Enrolling
Updated: 5/27/2010
Florida Academic Dermatology Center
mi
from
Miami, FL
Click here to add this to my saved trials
A Phase II Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas
A Phase II Study of Intratumoral Injection PF-3512676 in Combination With Local Radiation in Low-Grade B-Cell Lymphomas
Status: Enrolling
Updated:  6/1/2010
Stanford University School of Medicine
mi
from
Stanford, CA
A Phase II Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas
A Phase II Study of Intratumoral Injection PF-3512676 in Combination With Local Radiation in Low-Grade B-Cell Lymphomas
Status: Enrolling
Updated: 6/1/2010
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Cap Assisted Colonoscopy for the Detection of Colon Polyps
Prospective Randomized Controlled Study of Cap Assisted Colonoscopy for the Detection of Colon Polyps
Status: Enrolling
Updated:  9/28/2010
Veterans Affairs Medical Center
mi
from
Kansas City, MO
Cap Assisted Colonoscopy for the Detection of Colon Polyps
Prospective Randomized Controlled Study of Cap Assisted Colonoscopy for the Detection of Colon Polyps
Status: Enrolling
Updated: 9/28/2010
Veterans Affairs Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors
High-Dose Chemotherapy With Tandem Peripheral Blood Stem Cell (PBSC) Rescue for the Treatment of High-Risk Pediatric Solid Tumors.
Status: Enrolling
Updated:  10/7/2010
Children's Memorial Hospital
mi
from
Chicago, IL
Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors
High-Dose Chemotherapy With Tandem Peripheral Blood Stem Cell (PBSC) Rescue for the Treatment of High-Risk Pediatric Solid Tumors.
Status: Enrolling
Updated: 10/7/2010
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients
Status: Enrolling
Updated:  11/11/2010
Vanderbilt University Medical Center
mi
from
Nashville, TN
Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients
Status: Enrolling
Updated: 11/11/2010
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Dose-escalation Study of Oral CX-4945
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma
Status: Enrolling
Updated:  6/13/2011
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Dose-escalation Study of Oral CX-4945
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma
Status: Enrolling
Updated: 6/13/2011
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Dose-escalation Study of Oral CX-4945
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma
Status: Enrolling
Updated:  6/13/2011
Front Range Cancer Specialists
mi
from
Fort Collins, CO
Dose-escalation Study of Oral CX-4945
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma
Status: Enrolling
Updated: 6/13/2011
Front Range Cancer Specialists
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Dose-escalation Study of Oral CX-4945
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma
Status: Enrolling
Updated:  6/13/2011
Front Range Cancer Specialists
mi
from
Loveland, CO
Dose-escalation Study of Oral CX-4945
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma
Status: Enrolling
Updated: 6/13/2011
Front Range Cancer Specialists
mi
from
Loveland, CO
Click here to add this to my saved trials
Dose-escalation Study of Oral CX-4945
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma
Status: Enrolling
Updated:  6/13/2011
U T M D Anderson Cancer Center
mi
from
Houston, TX
Dose-escalation Study of Oral CX-4945
A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of CX-4945 Administered Orally to Patients With Advanced Solid Tumors, Castleman's Disease or Multiple Myeloma
Status: Enrolling
Updated: 6/13/2011
U T M D Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated:  6/22/2011
Albert Einstein Cancer Center
mi
from
Bronx, NY
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated: 6/22/2011
Albert Einstein Cancer Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated:  6/22/2011
Albert Einstein Cancer Center
mi
from
Bronx, NY
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated: 6/22/2011
Albert Einstein Cancer Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated:  6/22/2011
Albert Einstein Cancer Center at Albert Einstein College of Medicine
mi
from
Bronx, NY
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated: 6/22/2011
Albert Einstein Cancer Center at Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated:  6/22/2011
Albert Einstein Cancer Center at Albert Einstein College of Medicine
mi
from
Bronx, NY
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated: 6/22/2011
Albert Einstein Cancer Center at Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated:  6/22/2011
Albert Einstein Cancer Center at Albert Einstein College of Medicine
mi
from
Bronx, NY
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated: 6/22/2011
Albert Einstein Cancer Center at Albert Einstein College of Medicine
mi
from
Bronx, NY
Click here to add this to my saved trials
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated:  6/22/2011
Albert Einstein Clinical Cancer Center
mi
from
Bronx, NY
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated: 6/22/2011
Albert Einstein Clinical Cancer Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated:  6/22/2011
Albert Einstein Comprehensive Cancer Center
mi
from
Bronx, NY
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated: 6/22/2011
Albert Einstein Comprehensive Cancer Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated:  6/22/2011
Albert Einstein Comprehensive Cancer Center
mi
from
Bronx, NY
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated: 6/22/2011
Albert Einstein Comprehensive Cancer Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated:  6/22/2011
Montefiore Medical Center
mi
from
Bronx, NY
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated: 6/22/2011
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated:  6/22/2011
Montefiore Medical Center
mi
from
Bronx, NY
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated: 6/22/2011
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated:  6/22/2011
Montefiore Medical Center
mi
from
Bronx, NY
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated: 6/22/2011
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated:  6/22/2011
Montefiore Medical Center
mi
from
Bronx, NY
A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Phase II Study of Therapy With IMTOX-25 in Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated: 6/22/2011
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease
A Phase II Open Label, Multicenter, Randomized, Parallel Study Comparing the Efficacy of R-mabHD Alone and a Combination of Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD)in Treating Patients With Hodgkin's Disease.
Status: Enrolling
Updated:  7/19/2011
Raritan Bay Medical Center
mi
from
Englishtown, NJ
Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease
A Phase II Open Label, Multicenter, Randomized, Parallel Study Comparing the Efficacy of R-mabHD Alone and a Combination of Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD)in Treating Patients With Hodgkin's Disease.
Status: Enrolling
Updated: 7/19/2011
Raritan Bay Medical Center
mi
from
Englishtown, NJ
Click here to add this to my saved trials
Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma
Phase III Randomized, Multi-center Study to Evaluate the Effect of R-mabHDI in Patients With Lymphocytic Predominant Hodgkin's Lymphoma
Status: Enrolling
Updated:  7/19/2011
MedCenter
mi
from
East Brunswick, NJ
Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma
Phase III Randomized, Multi-center Study to Evaluate the Effect of R-mabHDI in Patients With Lymphocytic Predominant Hodgkin's Lymphoma
Status: Enrolling
Updated: 7/19/2011
MedCenter
mi
from
East Brunswick, NJ
Click here to add this to my saved trials
Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection
Mobilization Kinetics of Plerixafor and G-CSF in Patients With NHL and MM Undergoing Autologous Peripheral Blood Progenitor Cell Collection
Status: Enrolling
Updated:  9/26/2011
Mount Sinai School of Medicine
mi
from
New York, NY
Study of the Best Timing for Plerixafor in Autologous Hematopoietic Stem Cell Collection
Mobilization Kinetics of Plerixafor and G-CSF in Patients With NHL and MM Undergoing Autologous Peripheral Blood Progenitor Cell Collection
Status: Enrolling
Updated: 9/26/2011
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Lenalidomide in HTLV-1 Adult T-Cell Leukemia
A Phase II Study of Lenalidomide in Patients With Relapsed or Refractory HTLV-1 Associated Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated:  10/27/2011
Columbia University Medical Center
mi
from
New York, NY
Lenalidomide in HTLV-1 Adult T-Cell Leukemia
A Phase II Study of Lenalidomide in Patients With Relapsed or Refractory HTLV-1 Associated Adult T Cell Leukemia/Lymphoma
Status: Enrolling
Updated: 10/27/2011
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL)
A Phase I Study of Panobinostat in Combination With Bortezomib in the Treatment of Relapsed and/or Refractory Mantle Cell Lymphoma
Status: Enrolling
Updated:  1/4/2012
Georgia Health Sciences University
mi
from
Augusta, GA
Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL)
A Phase I Study of Panobinostat in Combination With Bortezomib in the Treatment of Relapsed and/or Refractory Mantle Cell Lymphoma
Status: Enrolling
Updated: 1/4/2012
Georgia Health Sciences University
mi
from
Augusta, GA
Click here to add this to my saved trials
Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia
Phase II Trial of CLAG-M in Relapsed ALL
Status: Enrolling
Updated:  1/19/2012
Westchester Medical Center/New York Medical College
mi
from
Valhalla, NY
Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia
Phase II Trial of CLAG-M in Relapsed ALL
Status: Enrolling
Updated: 1/19/2012
Westchester Medical Center/New York Medical College
mi
from
Valhalla, NY
Click here to add this to my saved trials
Safety and PK Study of RRx-001 in Cancer Subjects
A Phase I, Open-Label, Multiple Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of RRx-001 in Subjects With Advanced Solid Tumors or Lymphomas For Which There Are No Currently Accepted Curative Therapies
Status: Enrolling
Updated:  1/30/2012
Moores University of California San Diego Cancer Center
mi
from
La Jolla, CA
Safety and PK Study of RRx-001 in Cancer Subjects
A Phase I, Open-Label, Multiple Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of RRx-001 in Subjects With Advanced Solid Tumors or Lymphomas For Which There Are No Currently Accepted Curative Therapies
Status: Enrolling
Updated: 1/30/2012
Moores University of California San Diego Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Safety and PK Study of RRx-001 in Cancer Subjects
A Phase I, Open-Label, Multiple Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of RRx-001 in Subjects With Advanced Solid Tumors or Lymphomas For Which There Are No Currently Accepted Curative Therapies
Status: Enrolling
Updated:  1/30/2012
Sarah Cannon Research Institute
mi
from
Nashville, TN
Safety and PK Study of RRx-001 in Cancer Subjects
A Phase I, Open-Label, Multiple Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of RRx-001 in Subjects With Advanced Solid Tumors or Lymphomas For Which There Are No Currently Accepted Curative Therapies
Status: Enrolling
Updated: 1/30/2012
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit
A Phase I/II Trial of a Single FT1050 (16,16-Dimethyl Prostaglandin E2) Ex Vivo-Modulated Umbilical Cord Blood (CB) Unit Following a Reduced Intensity Conditioning Regimen For Adults With Hematologic Malignancies
Status: Enrolling
Updated:  2/3/2012
Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program
mi
from
Boston, MA
Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit
A Phase I/II Trial of a Single FT1050 (16,16-Dimethyl Prostaglandin E2) Ex Vivo-Modulated Umbilical Cord Blood (CB) Unit Following a Reduced Intensity Conditioning Regimen For Adults With Hematologic Malignancies
Status: Enrolling
Updated: 2/3/2012
Dana Farber Cancer Institute-Hematopoietic Stem Cell Transplant Program
mi
from
Boston, MA
Click here to add this to my saved trials
Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit
A Phase I/II Trial of a Single FT1050 (16,16-Dimethyl Prostaglandin E2) Ex Vivo-Modulated Umbilical Cord Blood (CB) Unit Following a Reduced Intensity Conditioning Regimen For Adults With Hematologic Malignancies
Status: Enrolling
Updated:  2/3/2012
Massachusetts General Hospital
mi
from
Boston, MA
Single Treatment With FT1050 of an Ex-vivo Modultated Umbilical Cord Blood Unit
A Phase I/II Trial of a Single FT1050 (16,16-Dimethyl Prostaglandin E2) Ex Vivo-Modulated Umbilical Cord Blood (CB) Unit Following a Reduced Intensity Conditioning Regimen For Adults With Hematologic Malignancies
Status: Enrolling
Updated: 2/3/2012
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials